The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Plasma Derived Drugs Market Research Report 2025
Synopsis
The global Plasma Derived Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Plasma Derived Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Derived Drugs.
Report Scope
The Plasma Derived Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plasma Derived Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasma Derived Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Grifols, S.A.
Octapharma
Antares Pharma
CSL Limited
Segment by Type
Immunoglobulins
Albumins
Clotting Factors
Others
Segment by Application
Hospitals
Speciality Clinics
Ambulatory Surgical Centers
Diagnostic Centers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Plasma Derived Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Plasma Derived Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Plasma Derived Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Plasma Derived Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Derived Drugs.
Report Scope
The Plasma Derived Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plasma Derived Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasma Derived Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Grifols, S.A.
Octapharma
Antares Pharma
CSL Limited
Segment by Type
Immunoglobulins
Albumins
Clotting Factors
Others
Segment by Application
Hospitals
Speciality Clinics
Ambulatory Surgical Centers
Diagnostic Centers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Plasma Derived Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Plasma Derived Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Plasma Derived Drugs Market Overview
1.1 Product Overview and Scope of Plasma Derived Drugs
1.2 Plasma Derived Drugs Segment by Type
1.2.1 Global Plasma Derived Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Immunoglobulins
1.2.3 Albumins
1.2.4 Clotting Factors
1.2.5 Others
1.3 Plasma Derived Drugs Segment by Application
1.3.1 Global Plasma Derived Drugs Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Speciality Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Diagnostic Centers
1.3.6 Others
1.4 Global Plasma Derived Drugs Market Size Estimates and Forecasts
1.4.1 Global Plasma Derived Drugs Revenue 2019-2030
1.4.2 Global Plasma Derived Drugs Sales 2019-2030
1.4.3 Global Plasma Derived Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Plasma Derived Drugs Market Competition by Manufacturers
2.1 Global Plasma Derived Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Plasma Derived Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Plasma Derived Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Plasma Derived Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Plasma Derived Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Plasma Derived Drugs, Product Type & Application
2.7 Plasma Derived Drugs Market Competitive Situation and Trends
2.7.1 Plasma Derived Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Plasma Derived Drugs Players Market Share by Revenue
2.7.3 Global Plasma Derived Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Plasma Derived Drugs Retrospective Market Scenario by Region
3.1 Global Plasma Derived Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Plasma Derived Drugs Global Plasma Derived Drugs Sales by Region: 2019-2030
3.2.1 Global Plasma Derived Drugs Sales by Region: 2019-2024
3.2.2 Global Plasma Derived Drugs Sales by Region: 2025-2030
3.3 Global Plasma Derived Drugs Global Plasma Derived Drugs Revenue by Region: 2019-2030
3.3.1 Global Plasma Derived Drugs Revenue by Region: 2019-2024
3.3.2 Global Plasma Derived Drugs Revenue by Region: 2025-2030
3.4 North America Plasma Derived Drugs Market Facts & Figures by Country
3.4.1 North America Plasma Derived Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Plasma Derived Drugs Sales by Country (2019-2030)
3.4.3 North America Plasma Derived Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Plasma Derived Drugs Market Facts & Figures by Country
3.5.1 Europe Plasma Derived Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Plasma Derived Drugs Sales by Country (2019-2030)
3.5.3 Europe Plasma Derived Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Plasma Derived Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Plasma Derived Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Plasma Derived Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Plasma Derived Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Plasma Derived Drugs Market Facts & Figures by Country
3.7.1 Latin America Plasma Derived Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Plasma Derived Drugs Sales by Country (2019-2030)
3.7.3 Latin America Plasma Derived Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Plasma Derived Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Plasma Derived Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Plasma Derived Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Plasma Derived Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Plasma Derived Drugs Sales by Type (2019-2030)
4.1.1 Global Plasma Derived Drugs Sales by Type (2019-2024)
4.1.2 Global Plasma Derived Drugs Sales by Type (2025-2030)
4.1.3 Global Plasma Derived Drugs Sales Market Share by Type (2019-2030)
4.2 Global Plasma Derived Drugs Revenue by Type (2019-2030)
4.2.1 Global Plasma Derived Drugs Revenue by Type (2019-2024)
4.2.2 Global Plasma Derived Drugs Revenue by Type (2025-2030)
4.2.3 Global Plasma Derived Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Plasma Derived Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Plasma Derived Drugs Sales by Application (2019-2030)
5.1.1 Global Plasma Derived Drugs Sales by Application (2019-2024)
5.1.2 Global Plasma Derived Drugs Sales by Application (2025-2030)
5.1.3 Global Plasma Derived Drugs Sales Market Share by Application (2019-2030)
5.2 Global Plasma Derived Drugs Revenue by Application (2019-2030)
5.2.1 Global Plasma Derived Drugs Revenue by Application (2019-2024)
5.2.2 Global Plasma Derived Drugs Revenue by Application (2025-2030)
5.2.3 Global Plasma Derived Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Plasma Derived Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Grifols, S.A.
6.1.1 Grifols, S.A. Corporation Information
6.1.2 Grifols, S.A. Description and Business Overview
6.1.3 Grifols, S.A. Plasma Derived Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Grifols, S.A. Plasma Derived Drugs Product Portfolio
6.1.5 Grifols, S.A. Recent Developments/Updates
6.2 Octapharma
6.2.1 Octapharma Corporation Information
6.2.2 Octapharma Description and Business Overview
6.2.3 Octapharma Plasma Derived Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Octapharma Plasma Derived Drugs Product Portfolio
6.2.5 Octapharma Recent Developments/Updates
6.3 Antares Pharma
6.3.1 Antares Pharma Corporation Information
6.3.2 Antares Pharma Description and Business Overview
6.3.3 Antares Pharma Plasma Derived Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Antares Pharma Plasma Derived Drugs Product Portfolio
6.3.5 Antares Pharma Recent Developments/Updates
6.4 CSL Limited
6.4.1 CSL Limited Corporation Information
6.4.2 CSL Limited Description and Business Overview
6.4.3 CSL Limited Plasma Derived Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CSL Limited Plasma Derived Drugs Product Portfolio
6.4.5 CSL Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Plasma Derived Drugs Industry Chain Analysis
7.2 Plasma Derived Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Plasma Derived Drugs Production Mode & Process
7.4 Plasma Derived Drugs Sales and Marketing
7.4.1 Plasma Derived Drugs Sales Channels
7.4.2 Plasma Derived Drugs Distributors
7.5 Plasma Derived Drugs Customers
8 Plasma Derived Drugs Market Dynamics
8.1 Plasma Derived Drugs Industry Trends
8.2 Plasma Derived Drugs Market Drivers
8.3 Plasma Derived Drugs Market Challenges
8.4 Plasma Derived Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Plasma Derived Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Plasma Derived Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Plasma Derived Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Plasma Derived Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Plasma Derived Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Plasma Derived Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Plasma Derived Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Plasma Derived Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Plasma Derived Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Plasma Derived Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Plasma Derived Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Plasma Derived Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Plasma Derived Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Derived Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Plasma Derived Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Plasma Derived Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Plasma Derived Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Plasma Derived Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Plasma Derived Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Plasma Derived Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Plasma Derived Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Plasma Derived Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Plasma Derived Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Plasma Derived Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Plasma Derived Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Plasma Derived Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Plasma Derived Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Plasma Derived Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Plasma Derived Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Plasma Derived Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Plasma Derived Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Plasma Derived Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Plasma Derived Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Plasma Derived Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Plasma Derived Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Plasma Derived Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Plasma Derived Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Plasma Derived Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Plasma Derived Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Plasma Derived Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Plasma Derived Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Plasma Derived Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Plasma Derived Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Plasma Derived Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Plasma Derived Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Plasma Derived Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Plasma Derived Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Plasma Derived Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Plasma Derived Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Plasma Derived Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Plasma Derived Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Plasma Derived Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Plasma Derived Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Plasma Derived Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Plasma Derived Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Plasma Derived Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Plasma Derived Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Plasma Derived Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Plasma Derived Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Plasma Derived Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Plasma Derived Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Plasma Derived Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Plasma Derived Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Plasma Derived Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Plasma Derived Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Plasma Derived Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Plasma Derived Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Plasma Derived Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. Grifols, S.A. Corporation Information
Table 71. Grifols, S.A. Description and Business Overview
Table 72. Grifols, S.A. Plasma Derived Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Grifols, S.A. Plasma Derived Drugs Product
Table 74. Grifols, S.A. Recent Developments/Updates
Table 75. Octapharma Corporation Information
Table 76. Octapharma Description and Business Overview
Table 77. Octapharma Plasma Derived Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Octapharma Plasma Derived Drugs Product
Table 79. Octapharma Recent Developments/Updates
Table 80. Antares Pharma Corporation Information
Table 81. Antares Pharma Description and Business Overview
Table 82. Antares Pharma Plasma Derived Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Antares Pharma Plasma Derived Drugs Product
Table 84. Antares Pharma Recent Developments/Updates
Table 85. CSL Limited Corporation Information
Table 86. CSL Limited Description and Business Overview
Table 87. CSL Limited Plasma Derived Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. CSL Limited Plasma Derived Drugs Product
Table 89. CSL Limited Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Plasma Derived Drugs Distributors List
Table 93. Plasma Derived Drugs Customers List
Table 94. Plasma Derived Drugs Market Trends
Table 95. Plasma Derived Drugs Market Drivers
Table 96. Plasma Derived Drugs Market Challenges
Table 97. Plasma Derived Drugs Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Plasma Derived Drugs
Figure 2. Global Plasma Derived Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Plasma Derived Drugs Market Share by Type in 2023 & 2030
Figure 4. Immunoglobulins Product Picture
Figure 5. Albumins Product Picture
Figure 6. Clotting Factors Product Picture
Figure 7. Others Product Picture
Figure 8. Global Plasma Derived Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Plasma Derived Drugs Market Share by Application in 2023 & 2030
Figure 10. Hospitals
Figure 11. Speciality Clinics
Figure 12. Ambulatory Surgical Centers
Figure 13. Diagnostic Centers
Figure 14. Others
Figure 15. Global Plasma Derived Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Plasma Derived Drugs Market Size (2019-2030) & (US$ Million)
Figure 17. Global Plasma Derived Drugs Sales (2019-2030) & (K Units)
Figure 18. Global Plasma Derived Drugs Average Price (US$/Unit) & (2019-2030)
Figure 19. Plasma Derived Drugs Report Years Considered
Figure 20. Plasma Derived Drugs Sales Share by Manufacturers in 2023
Figure 21. Global Plasma Derived Drugs Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Plasma Derived Drugs Players: Market Share by Revenue in 2023
Figure 23. Plasma Derived Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Plasma Derived Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Plasma Derived Drugs Sales Market Share by Country (2019-2030)
Figure 26. North America Plasma Derived Drugs Revenue Market Share by Country (2019-2030)
Figure 27. U.S. Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Plasma Derived Drugs Sales Market Share by Country (2019-2030)
Figure 30. Europe Plasma Derived Drugs Revenue Market Share by Country (2019-2030)
Figure 31. Germany Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Plasma Derived Drugs Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Plasma Derived Drugs Revenue Market Share by Region (2019-2030)
Figure 38. China Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Taiwan Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Philippines Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Latin America Plasma Derived Drugs Sales Market Share by Country (2019-2030)
Figure 49. Latin America Plasma Derived Drugs Revenue Market Share by Country (2019-2030)
Figure 50. Mexico Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Brazil Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Argentina Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Middle East & Africa Plasma Derived Drugs Sales Market Share by Country (2019-2030)
Figure 54. Middle East & Africa Plasma Derived Drugs Revenue Market Share by Country (2019-2030)
Figure 55. Turkey Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. UAE Plasma Derived Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Global Sales Market Share of Plasma Derived Drugs by Type (2019-2030)
Figure 59. Global Revenue Market Share of Plasma Derived Drugs by Type (2019-2030)
Figure 60. Global Plasma Derived Drugs Price (US$/Unit) by Type (2019-2030)
Figure 61. Global Sales Market Share of Plasma Derived Drugs by Application (2019-2030)
Figure 62. Global Revenue Market Share of Plasma Derived Drugs by Application (2019-2030)
Figure 63. Global Plasma Derived Drugs Price (US$/Unit) by Application (2019-2030)
Figure 64. Plasma Derived Drugs Value Chain
Figure 65. Plasma Derived Drugs Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
